Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pharming Group NV
PHGNCurrent price
0.72 EUR
-0.015 EUR (-2.05%)
Last closed
0.75 EUR
Company
www.pharming.com
ISIN
NL0010391025
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
517 824 065 EUR
Yield for 12 month
-33.47 %
1Y
3Y
5Y
10Y
15Y
PHGN
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. Address: Darwinweg 24, Leiden, Netherlands, 2333 CR
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.41 EURP/E ratio
–Dividend Yield
–Current Year
+247 211 564 EUR
Last Year
+207 210 847 EUR
Current Quarter
+75 427 360 EUR
Last Quarter
+74 665 518 EUR
Current Year
+221 804 750 EUR
Last Year
+189 513 145 EUR
Current Quarter
+68 555 669 EUR
Last Quarter
+66 622 850 EUR
Key Figures PHGN
1 year
3 years
5 years
10 years
EBITDA
-3 080 621 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-1.38 %
PEG Ratio
–
Return On Equity TTM
-8.18 %
Wall Street Target Price
1.41 EUR
Revenue TTM
287 952 952 EUR
Book Value
0.44 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12.2 %
Dividend Yield
–
Gross Profit TTM
189 513 145 EUR
Earnings per share
-0.03 EUR
Diluted Eps TTM
-0.03 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-61.5 %
Profit Margin
-6.24 %
Dividend Analytics PHGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PHGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
05.03.2013
Dividend Date
–
Stock Valuation PHGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
172.4138
Enterprise Value Revenue
1.7348
Price Sales TTM
1.7983
Enterprise Value EBITDA
65.6059
Price Book MRQ
2.4323
Financials PHGN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHGN
For 52 weeks
0.65 EUR
1.2 EUR
50 Day MA
0.74 EUR
Shares Short Prior Month
–
200 Day MA
0.85 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart